More Bad News

http://www.lifeabc.org/risk_recurrence_more.html

“Another analysis of recurrence among ER+ patients found that use of tamoxifen therapy significantly improved patient outcomes in a population considered to be at minimal risk prior to this trial. However, even with adjuvant therapy, more than 20% of node-negative patients had their disease recur within 15 years after diagnosis. 11

Ah, not that encouraging, is it?

some other links, mostly for my reference

http://www.ncbi.nlm.nih.gov/pubmed/8690632

http://www.breastcancer.org/treatment/hormonal/new_research/20081010b.jsp

 

 

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s